![Dominic Piscitelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Piscitelli
Director of Finance/CFO at
ORIC PHARMACEUTICALS, INC.
Net worth: 575 851 $ as of 30/05/2026
Profile
Dominic Piscitelli is currently an Independent Director at Celyad Oncology SA since 2020, an Independent Director at Alterome Therapeutics, Inc. since 2024, and Chief Financial Officer at Oric Pharmaceuticals, Inc. since 2019.
Former roles include Chief Financial Officer at AnaptysBio, Inc. from 2017 to 2019, VP-Finance, Strategy & Investor Relations at Medivation LLC (California) from 2012 to 2017, Director-Collaborations & Operations Finance at Astellas Pharmaceuticals SA from 2011 to 2012, and Vice President-Treasury & Management Finance at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Education includes undergraduate and MBAistration degrees from Hofstra University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2026 | 68,148 ( 0.07% ) | 575 851 $ | 30/05/2026 |
Dominic Piscitelli active positions
| Companies | Position | Start |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/08/2019 |
| CELYAD ONCOLOGY SA | Director/Board Member | 05/05/2020 |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Director/Board Member | 31/03/2024 |
Former positions of Dominic Piscitelli
| Companies | Position | End |
|---|---|---|
| ANAPTYSBIO, INC. | Director of Finance/CFO | 15/08/2019 |
| MEDIVATION INC | Director of Finance/CFO | 31/12/2016 |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 31/08/2012 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Dominic Piscitelli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Hofstra University
 Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Astellas Pharmaceuticals SA | |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Health Technology |
- Stock Market
- Insiders
- Dominic Piscitelli
